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REVIEW ARTICLE
Psychotherapy for posttraumatic stress disorder in patients with borderline 
personality disorder: a systematic review and meta-analysis of its efficacy and 
safety
Christina W. Slotemaa, Bobbie Wilhelmusa, Lidia R. Arendsb and Ingmar H. A. Frankenb
aDepartment of Personality Disorders, Parnassia Psychiatric Institute, The Hague, the Netherlands; bDepartment of Psychology, 
Education and Child Studies, Erasmus University Rotterdam, Rotterdam, the Netherlands
ABSTRACT
Background: Posttraumatic stress disorder (PTSD) is common in patients with personality 
disorders. This comorbidity is accompanied by a lower quality of life, and a higher risk of 
suicide attempts than patients with only one of these diagnoses.
Objective: The aim of this systematic review and meta-analysis was to evaluate the scientific 
evidence of the efficacy of PTSD treatments for this population.
Method: A literature search was performed from 1946 through June 2020. Standardized 
mean effect sizes of psychotherapy for PTSD were computed.
Results: The literature search revealed that psychotherapy was the only intervention that 
was systematically explored. Fourteen studies were included. In 12 of these studies solely 
patients with borderline personality disorder participated. Analysis of the four RCTs showed 
a significant, moderate to high standardized effect size for reducing PTSD symptom severity 
(Hedges’ g = 0.54), with effects being maintained at least 3 months (Hedges’ g = 0.82). Effect 
sizes for all studies were also significant, with moderate to high standardized values for 
symptoms of PTSD (Hedges’ g = 1.04). PTSD improvements were again maintained at 
3-month follow-up and beyond (Hedges’ g = 0.98). In addition, a significant decrease in 
symptoms of depression, anxiety, borderline symptoms, and PTSD in patients with border-
line personality disorder could be revealed for all studies (Hedges’ g 0.48–1.04). No increase 
in self-injurious behaviour, suicide attempts, or hospitalization was observed, while the 
mean weighted dropout rate during PTSD treatment was 17%.
Conclusions: Psychotherapy for PTSD is efficacious and safe for patients with borderline 
personality disorder and should not be withheld from these vulnerable individuals.
Psicoterapia para el trastorno de estres postraumático en pacientes 
con trastorno límite de la personalidad: una revisión sistemática 
y metanálisis de su eficacia y seguridad 
Antecedentes: El trastorno de estrés postraumático (TEPT) es común en pacientes con 
trastornos de la personalidad. Esta comorbilidad se acompaña de una menor calidad de 
vida y un mayor riesgo de intentos de suicidio que los pacientes con solo uno de estos 
diagnósticos. 
Objetivo: El propósito de esta revisión sistemática y metanálisis fue evaluar la evidencia 
científica de la eficacia de los tratamientos de TEPT para esta población. 
Método: Se realizó una búsqueda bibliográfica desde 1946 hasta junio de 2020. Se calcu-
laron los tamaños de efecto promedio estandarizados de la psicoterapia para el TEPT. 
Resultados: La búsqueda de la literatura reveló que la psicoterapia fue la única intervención 
explorada sistemáticamente. Se incluyeron catorce estudios. En doce de estos estudios 
participaron únicamente pacientes con trastorno límite de la personalidad. El análisis de 
los cuatro ECA mostró un tamaño de efecto estandarizado significativo, moderado a alto, 
para reducir la gravedad de los síntomas de TEPT (Hedges’ g = 0.54), con efectos que se se 
mantenían al menos tres meses (Hedges’ g = 0.82). Los tamaños del efecto para todos los 
estudios también fueron significativos, con valores estandarizados moderados a altos para 
síntomas de TEPT (Hedges’ g = 1.04). Las mejoras del TEPT también se mantuvieron a los 3 
meses de seguimiento y más allá (Hedges’ g = 0.98). Adicionalmente, en todos los estudios 
podría ser revelada una disminución significativa de los síntomas de depresión, ansiedad, 
síntomas límite y trastorno de estrés postraumático en pacientes con trastorno límite de la 
personalidad (Hedges‘g 0.48 – 1.04). No se observó aumento en el comportamiento auto-
lesivo, intentos de suicidio u hospitalización, mientras que la tasa de abandono ponderada 
media durante el tratamiento del TEPT fue del 17%. 
Conclusiones: La psicoterapia para el trastorno de estrés postraumático es eficaz y segura 
para pacientes con trastorno límite de la personalidad y no debiera ser negada a estos 
individuos vulnerables. 
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HIGHLIGHTS:
• Psychotherapy reduces 
PTSD symptom severity in 
patients with borderline 
personality disorder. 
• The duration of the 
reduction of PTSD symptom 
severity after psychotherapy 
is at least three months. 
• Risks associated with 
psychotherapy for PTSD are 
low in this population.
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边缘型人格障碍患者创伤后应激障碍的心理治疗：一项有效性和安全性 
的系统综述和元分析  




结果: 文献检索表明, 心理治疗是唯一被系统性探讨的干预措施。纳入了十四项研究。其 
中12项研究只有边缘性人格障碍患者参与了研究。对四个随机对照试验的分析显示了 
PTSD症状严重程度下降具有中等到较高的显著标准化效应量 (Hedges g= 0.54), 并且效果 
至少维持了三个月 (Hedges g= 0.82) 。所有研究的效应量也显著, PTSD症状具有中等至较 
高的标准化值 (Hedges g= 1.04) 。 PTSD的改善在3个月及以后的随访中均得以维持 
(Hedges g= 0.98) 。此外, 所有研究均显示, 边缘性人格障碍患者的抑郁, 焦虑, 边缘性症状 
和PTSD症状显著减少 (Hedges’ g :0.48– 1.04) 。没有发现自残行为, 自杀企图或住院的增加, 
而PTSD治疗期间的平均加权退出率为17％。 
结论: 对于边缘型人格障碍的患者, PTSD的心理治疗是有效且安全的, 不应被这些易受伤个 
体拒绝。   
1. Introduction
Posttraumatic stress disorder (PTSD) is a severe mental 
disorder characterized by traumatic intrusions and the 
persistent avoidance of stimuli associated with the trau-
matic event(s) (American Psychiatric Association, 
2013). Its lifetime prevalence in the general population 
varies between 1.3% in Japan and 9.2% in the US 
(Atwoli, Stein, Koenen, & McLaughlin, 2015). PTSD is 
associated with serious consequences for the people 
suffering from the syndrome, affecting their daily func-
tioning and quality of life, while increasing the use of 
health and social services (Atwoli et al., 2015).
With relaxation training and medication being offered 
widely, of all available interventions for PTSD, psy-
chotherapy is the treatment of choice. Several meta- 
analyses have evaluated the efficacy of such PTSD pro-
grammes (Bisson et al., 2007; Carpenter et al., 2018; Chen 
et al., 2014; Ehring et al., 2014; Khan et al., 2018; Lewis, 
Roberts, Andrew, Starling, & Bisson, 2020). In their meta- 
analysis of treatments for chronic PTSD, Bisson et al. 
found cognitive-behavioural therapy (CBT), eye move-
ment desensitization and reprocessing (EMDR), and 
stress management to be superior to a waiting-list condi-
tion and usual care, finding moderate to high standar-
dized mean differences (i.e. 0.43 up to 1.51) (2007). 
Comparing CBT, trauma-focused CBT, EMDR, and 
other interpersonal, emotion-focused treatments, 
Ehring et al. (2014) obtained an effect size of 0.72 for 
psychotherapy for patients suffering from PTSD resulting 
from childhood abuse. In a third meta-analysis, EMDR 
was found to significantly reduce symptoms of PTSD, 
depression, anxiety, and subjective distress, with effect 
sizes ranging from 0.64 to 0.96 (Chen et al., 2014). 
A recent increase in randomized-controlled trials of psy-
chological therapies for PTSD, resulted in a more con-
fident recommendation of trauma-focused CBT and 
EMDR as the first-line treatments (Lewis et al., 2020). 
In addition, the findings of a meta-analysis of Khan and 
colleagues suggest that EMDR may be better than CBT in 
reducing posttraumatic symptoms and anxiety (Khan 
et al., 2018).
In these meta-analyses, treatments all targeted 
patients diagnosed with PTSD without the presence 
or absence of comorbid disorders being investigated 
or reported. The results can therefore not be extra-
polated to patients with known comorbid conditions 
such as personality disorders. Already coping with 
impairments in cognition, emotion regulation, inter-
personal functioning, and impulse control, arguably, 
this group is even more vulnerable to trauma; 
reported rates of childhood abuse are, for instance, 
high. Systematic knowledge about PTSD in this 
population is, however, mostly restricted to patients 
with a borderline personality disorder (BPD), who 
have a prevalence rate up to 3% within the normal 
population (Samuals et al., 2002). Childhood mal-
treatment in terms of verbal, physical, and sexual 
abuse, has been reported in 72%, 46% and 26%, 
respectively (Zanarini, Gunderson, Marino, 
Schwartz, & Frankenburg, 1989).
With prevalence rates of 34% to 46% being men-
tioned, PTSD is quite common in patients with BPD 
(Slotema, Blom, Niemantsverdriet, Deen, & Sommer, 
2018; Zanarini et al., 1998). Due to this comorbidity, 
they are known to have a lower quality of life, other 
comorbid disorders, a higher risk of suicide attempts, 
and a higher prevalence of childhood trauma than 
patients with only one of the diagnoses (Pagura et al., 
2010). Within patients with BPD and comorbid 
PTSD, it is recommended that management of suici-
dal and non-suicidal self-injury behaviours take place 
before the onset of trauma-focused treatment 
(Ursano et al., 2004). However, the exclusion of 
patients with this behaviour seems problematic as 
many of these patients exhibit this behaviour in 
order to reduce their suffering from intrusions or 
dissociative states (Albach & Everaerd, 1992; Amir, 
Kaplan, Efroni, & Kotler, 1999). Lastly, Zanarini et al. 
documented a prevalence rate of PTSD for 
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personality disorders other than BPD of 22% in an 
American sample of inpatients (Zanarini et al., 1998).
In 2001, Cloitre and Koenen were the first to 
report on a clinical trial evaluating interpersonal pro-
cess group therapy in female patients with PTSD and 
personality disorders (2001). They found that in the 
subgroup of women with BPD, PTSD symptoms had 
not improved. Since then, more clinical trials have 
been conducted, some of which did observe a positive 
influence of psychotherapy on the severity of PTSD 
in personality disorders. We accordingly felt it was 
opportune to examine the evidence on the efficacy of 
PTSD interventions in these vulnerable patients. In 
the present systematic review and meta-analysis we 
sought to answer the following questions: 1. Can we 
quantify the effects of PTSD treatment on the severity 
of PTSD-related symptoms in patients with all types 
of personality disorders? 2. Does PTSD treatment 
ameliorate other symptoms unrelated to the PTSD, 
such as depression, anxiety and borderline symp-
toms? 3. What is the outcome of PTSD treatment 
on PTSD symptom severity in patients with BPD? 
And 4. What is known about the effects of PTSD 
treatment on PTSD symptom severity three months 
after treatment conclusion and beyond?
In our systematic review of the relevant literature, 
we were curious to learn what has been reported 
about the risks assumed to be associated with PTSD 
interventions in comorbid populations, such as suici-
dal – and nonsuicidal self-injurious behaviour, and 
the number of patients dropping out of the trauma- 
focused treatments.
2. Methods
The review protocol was registered with The 
International Prospective Register of Systematic 
Reviews (PROSPERO), number of identification 
CRD42020144999 and conducted conform PRISMA 
guidelines for systematic reviews.
2.1. Literature search
A systematic search of the literature was conducted 
by two independent reviewers using Medline and 
Pre-Medline (PubMed alike) 1946 to June 2020, 
EMBASE 1974 to June 2020, and PsycINFO 1806 to 
June 2020 with the following key words: posttrau-
matic stress disorder, personality disorder and treat-
ment for PTSD. The Boolean connector AND was 
used to combine the three key words.
The exact literature search was as follows:
A search of the literature was conducted using 
Medline and Pre-Medline (PubMed alike) 1946 – 
June 2020, EMBASE 1974 to June 2020, and 
PsycINFO 1806 – June 2020 with the search terms:
(personality disorders, antisocial personality disor-
der, borderline personality disorder, compulsive per-
sonality disorder, dependent personality disorder, 
histrionic personality disorder, hysteria, paranoid 
personality disorder, passive-aggressive personality 
disorder, schizoid personality disorder, schizotypal 
personality disorder, narcissism, narcissistic person-
ality disorder, obsessive-compulsive personality dis-
order, stress disorders, schizoidism, borderline state, 
character disorder, Diogenes syndrome, psychopathy, 
compulsion, obsession, dark triad, avoidant person-
ality disorder, obsessive personality, hoarding disor-
der, narcissus or sadomasochistic personality)
AND (post-traumatic, PTSD, posttraumatic stress 
disorder, or post-traumatic stress disorder, complex 
PTSD, or DESNOS)
AND (therapeutics, psychiatry, psychology, clinical, 
emergency services, psychiatric, electroshock, pharmaco-
logical actions, treatment outcome, treatment failure, 
program(me) evaluation, therapy, diet, therapy, drug 
therapy, health care, therapeutic processes, rehabilitation, 
psychotherapy, program, intervention, counsel, pharma-
cotherapy, medication, drug, lifestyle, coaching, clinical 
psychology, clinical outcome, patient-reported outcome, 
psychiatric treatment, psychopharmacology, psychotro-
pic agent, treatment, effectiveness evaluation, counsel-
ling, couples therapy, client treatment matching, 
posttreatment, follow-up, prescribing, side effects, or fol-
low-up)
Titles and abstracts were screened with the aid of 
the inclusion criteria. Any uncertainties and disagree-
ments were discussed until consensus was reached. 
The website Google Scholar was examined to identify 
additional studies that had not yet been included in 
the aforementioned databases by checking the cita-
tions of the studies that were included into the sys-
tematic review. Furthermore, a hand search of 
reference lists of all relevant papers and major 
reviews was conducted.
2.2. Inclusion criteria
For our meta-analyses, we used the following nine inclu-
sion criteria: 1. Presence of current PTSD according to 
the Diagnostic and Statistical Manual of Mental 
Disorders IV and 5 (DSM-IV and −5), 2. Presence of 
a personality disorder according to the DSM-IV and −5, 
3. Outcome measures including PTSD symptom severity 
assessed using a validated instrument (self-report or 
structured clinical interview), 4. Randomized- 
controlled, nonrandomized, or uncontrolled studies 
design, 5. A control condition other than treatment for 
PTSD in case of a randomized-controlled design, 6. At 
least pre- and post-treatment assessments or a pre- 
treatment and at least one follow-up assessment, 7. 
Written in English, 8. Published in a peer-reviewed jour-
nal, and 9. Sufficient data for the computation of 
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standardized effect sizes (i.e. sample size, means, standard 
deviations (SDs), or exact t, F or p values) for the main 
effect for change scores.
We intended to perform a meta-analysis if at least 
three randomized-controlled trials (RCTs) could be 
included, where we regarded RCTs comparing at least 
one active treatment to at least one control condition 
as the gold standard. However, in a developing 
research area such as this, with a small number of 
RCTs having been conducted, it may be useful to also 
include studies with weaker designs. Therefore, we 
performed separate meta-analyses for RCTs and the 
total number of eligible studies identified, including 
nonrandomized and uncontrolled research reports. 
Publications that failed to meet criterion 8 (sufficient 
data) but did report whether the change in PTSD 
severity was significant, were excluded from the 
meta-analyses but nevertheless considered relevant 
and included in our qualitative review.
2.3. Data extraction
Data were extracted and reviewed by two authors 
independently of each other according to the current 
review protocol and checked against the original 
manuscripts. The data collected for the meta- 
analyses comprised the number of patients per treat-
ment condition, pre- and posttreatment means and 
SDs for PTSD symptom severity at baseline and at the 
end of treatment, or exact F, t, or p values. In addi-
tion, we documented the study design, population(s) 
(i.e. type of personality disorders), type of trauma, 
type of treatment, and the number and duration of 
sessions.
When publications contained insufficient and/or 
incomplete results, the authors were approached per-
sonally with a request to grant access to any addi-
tional data. The analysis was restricted to the largest 
sample size in the case of different publications with 
overlapping patient samples. If PTSD symptom sever-
ity was assessed with both a structured clinical inter-
view and a self-report instrument, the first was used 
for the meta-analysis. Comparators other than treat-
ment for PTSD were accepted as control condition in 
RCTs. Examples of control conditions are waiting list, 
treatment as usual for personality disorders and psy-
cho-education.
2.4. Computation of effect sizes
We opted for the mean weighted effect size, 
Hedges’ g, which was computed with the aid of 
the Comprehensive Meta-Analysis, Version 3 
(Biostat, Englewood, NJ). The analyses were per-
formed in a random-effects model given that 
Hedges’ g is a standardized effect-size measure 
that corrects for the bias introduced by using the 
sample SD of treatment responses instead of the 
population SD. Effect sizes (Hedges’ g) were calcu-
lated for the mean change in PTSD symptom sever-
ity (pre-to-posttreatment states) for the separate 
study conditions and divided by the SD reported 
in the study. If posttreatment data were absent, 
data derived from follow-up measurements were 
used. In studies reporting on more than one treat-
ment arm and a control condition, the active treat-
ments were each compared separately with the 
placebo condition. Finally, meta-analytic methods 
were used to obtain a pooled, standardized effect 
size.
2.5. Heterogeneity
We used a random-effects model in order to account 
for variation among studies. A homogeneity statistic, I2, 
was computed to test whether the studies could be taken 
to share a common population effect size (Higgins & 
Thompson, 2002). Furthermore, heterogeneity in the 
effect sizes obtained for the various studies was deter-
mined by means of a moderator analysis again using the 
Comprehensive Meta-Analysis method. The para-
meters entered into the analyses were: type of 
population(s) dichotomously categorized as patients 
with personality disorders or BPD, type of psychother-
apy, treatment intensity in terms of the total number of 
minutes, nature of the intervention, i.e. stand-alone or 
add-on treatment, individual, group, or a combination 
of individual and group therapy, and treatment venue, 
i.e. in- or outpatient setting. Q-values represent the 
results of these analyses. This value consists of 
a weighted sum of squared deviations around the 
mean of the effect in each study (DerSimonian & 
Laird, 1986). The Benjamini-Hochberg procedure was 
used to correct for multiple testing (Benjamini & 
Hochberg, 1995). In this procedure the individual 
P values are placed in order, from smallest to largest, 
and compared to the Benjamini-Hochberg critical 
value, i.e., 0.05 divided by the rank of the individual 
P value. The P values below this critical value are 
significant.
2.6. Publication bias
Because effect sizes can be over- or underestimated 
due to the absence of studies with negative results, 
a fail-safe number was computed, that is, an estima-
tion of the number of missing studies necessary to 
change the results of the meta-analysis from signifi-
cant to nonsignificant (Rosenthal, 1997). In addition, 
a funnel plot was created to visually examine the 
potential influence of publication bias. Egger’s regres-
sion intercept was used as a formal test of funnel-plot 
asymmetry (Egger, Smith, Schneider, & Minder, 
1997).
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2.7. Quality of studies
The quality of all eligible publications was inspected 
based on the following criteria: Was PTSD diagnosed 
using a structural clinical interview? Were random 
sequence generation and masked outcome assess-
ments applied? Were the number of withdrawals 
during treatment and tolerability reported on? Were 
outcomes re-assessed at follow-up in addition to 
post-treatment and intention-to-treat analyses? 
These criteria were based on the validity assessment 
method of Bisson and colleagues (Bisson et al., 2007).
2.8. Dropout
A mean-weighted dropout rate was computed, with 
dropout being defined as the percentage of the total 




3.1.1. Characteristics of eligible studies
The literature search revealed a total number of hits of 
925 for Medline, 3358 for EMBASE and 179 for 
PsycINFO. The reasons for exclusion are listed in 
Figure 1. Of the same 3888 studies, 3871 did not 
meet our inclusion criteria for a systematic review. 
Seventeen studies (with a total of 509 patients) were 
included for review, comprising eight RCTs (totalling 
225 patients), two controlled studies (totalling 33 
patients), and seven open-label studies (totalling 251 
patients) (see Table 1 part A and B). Data regarding 
treatment, outcome measures, and population types 
are presented in Table 1. In all 17 studies, psychother-
apy was the intervention used to treat PTSD; in 
approximately half, the therapy was offered as an addi-
tion to other ongoing treatments unrelated to PTSD 
(Harned, Korslund, & Linehan, 2014; Kredlow et al., 
2017; Pabst et al., 2014; Slotema, van den Berg, 
Driessen, Wilhelmus, & Franken, 2019; Steuwe et al., 
2016; Walter, Bolte, Owens, & Chard, 2012). Fourteen 
of the 17 studies reviewed reported a statistically sig-
nificant reduction in PTSD symptom severity.
3.1.2. PTSD treatments provided
Psychotherapy was the only PTSD intervention evaluated 
in patients with personality disorders, of which prolonged 
exposure (PE) therapy was the intervention most fre-
quently offered (5 studies)(Feeny, Zoellner, & Foa, 2002; 
Harned, Korslund, Foa, & Linehan, 2012; Harned et al., 
2014; Hembree, Cahill, & Foa, 2004; Meyers et al., 2017). 
In three of these studies, PE was combined with 
Figure 1. Flowchart of studies exploring the effects of psychotherapy of posttraumatic stress disorder (PTSD) in patients with 
personally disorders.
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dialectical behavioural therapy (DBT)(Harned et al., 
2012, 2014; Meyers et al., 2017). Two other studies offered 
DBT in combination with other trauma-focused inter-
ventions (Bohus et al., 2013; Steil et al., 2018), while the 
efficacy of CBT was explored in three studies (Clarke, 
Rizvi, & Resick, 2008; Kredlow et al., 2017). Two studies 
assessed the effects of cognitive processing therapy (CPT) 
(Holder, Holliday, Pai, & Surís, 2017; Walter et al., 2012) 
and two the outcomes of narrative exposure therapy 
(NET)(Pabst et al., 2014; Steuwe et al., 2016). EMDR 
was studied by our group (Slotema et al., 2019) and 
interpersonal process group therapy also in a single 
study (Cloitre & Koenen, 2001). A combination of 
EMDR, PE with physical training and psycho-education 
was offered in one study (De Jongh et al., 2020).
The trauma-focused treatments were offered in an 
individual setting in the majority of the studies, while 
seven provided a combination of group and indivi-
dual therapy (Bohus et al., 2013; Clarke et al., 2008; 
Harned et al., 2012; Hembree et al., 2004; Meyers 
et al., 2017; Steil et al., 2018; Walter et al., 2012), 
with one investigating group therapy. In four studies, 
treatments were delivered in an inpatient setting 
(Bohus et al., 2013; De Jongh et al., 2020; Steuwe 
et al., 2016; Walter et al., 2012), in one both in an 
in- and an outpatient setting (Pabst et al., 2014), and 
the other 12 studies all had outpatient settings.
The PTSD interventions comprised a mean or 
median of 4 up to 25 sessions and session durations 
ranged between 50 and 120 min, while treatment 
intensity varied between 300 and 7,280 minutes.
3.1.3. Populations and trauma types
The majority of studies included patients with BPD; 
only three studies explored the efficacy of PTSD treat-
ments in personality disorders in general (Hembree 
et al., 2004; Slotema et al., 2019; Walter et al., 2012). 
Hembree and colleagues included 29 patients with the 
following personality disorders: avoidant – (28%), 
obsessive-compulsive – (24%), depressive – (24%), 
borderline – (10%), and negativistic -, schizoid -, anti-
social – and narcissistic personality disorder (3% 
each). The population of Walter and colleagues con-
sisted of 110 patients with paranoid – (45%), avoi-
dant – (30%), borderline – (15%), obsessive- 
compulsive – (11%), passive-aggressive – (4%), 
depressive – (6%), dependent – (5%), antisocial – 
(3%), narcissistic – (2%) and schizotypal personality 
disorder (1%). In the study of Slotema and colleagues 
47 patients with the following personality disorders 
participated: borderline – (47%), unspecified – 
(43%), and paranoid -, antisocial -, narcissistic -, avoi-
dant – and dependent personality disorder (2% each).
In seven studies both male and female patients 
participated (De Jongh et al., 2020; Kredlow et al., 
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et al., 2016; Walter et al., 2012), with the other studies 
evaluating treatments in female patients only.
The following traumas were reported: childhood 
sexual abuse and other traumas in nine studies (De 
Jongh et al., 2020; Harned et al., 2012, 2014; Hembree 
et al., 2004; Kredlow et al., 2017; Slotema et al., 2019; 
Steuwe et al., 2016; Walter et al., 2012), childhood 
sexual abuse in three studies (Bohus et al., 2013; 
Cloitre & Koenen, 2001; Steil et al., 2018), sexual 
and nonsexual assault in two (Feeny et al., 2002; 
Pabst et al., 2014), and military sexual assault, mili-
tary assault and sexual assault in one, respectively 
(Clarke et al., 2008; Holder et al., 2017; Meyers 
et al., 2017).
3.1.4. Safety of PTSD treatment
During the treatment phase, the severity of self- 
injurious behaviour was reduced in three studies 
(Bohus et al., 2013; Harned et al., 2014; Steil et al., 
2018), with results in one study being similar to those 
in the control condition (DBT)(Harned et al., 2014). 
None of the patients showed an increase in any 
problematic behaviour, such as suicidality, self- 
harm, or need for hospitalization (Meyers et al., 
2017; Slotema et al., 2019; Steil et al., 2018). Suicide 
attempts during the treatment phase were absent in 
three studies (Bohus et al., 2013; Slotema et al., 2019; 
Steil et al., 2018), but in both the studies of Harned 
and colleagues one patient did try to commit suicide, 
which was not an increase from baseline (Harned 
et al., 2012, 2014). No suicide attempts occurred in 
the DBT control group.
3.1.5. Dropout
The patients leaving the PTSD interventions prematurely 
are presented in Table 1. Dropout rates varied between 
0% and 36%, with a mean weighted dropout of 17%.
3.2. Meta-analyses
A total of 3888 studies were considered, of which 
3874 did not fulfil our criteria for meta-analysis. 
The reasons for exclusion are presented in Figure 1. 
Fourteen studies comprising a total of 430 patients 
were found fit for inclusion; the details of these 
studies are described in Table 1, part A. Of the 
selected studies, four were RCTs with a total of 78 
patients participating in the active condition and 63 
in the control condition. Another two RCTs were 
treated as uncontrolled trials as the data on patients 
with personality disorders in the control condition 
were lacking (Feeny et al., 2002; Holder et al., 2017). 
Two further RCTs were only included in the systema-
tic review because the data were not sufficient for 
statistical evaluation (Clarke et al., 2008; Hembree 
et al., 2004). No studies regarding other interventions 
than psychotherapy could be included.
3.2.1. Quality of studies
The results on the methodological quality of studies 
included in the meta-analyses are presented in Table 2. 
Eleven studies used a structured clinical interview to 
diagnose or confirm PTSD (79%) and in nine of these 
the interviewers were blind (64%). In the study of 
Slotema et al. (2019) patients participated if they had 
a diagnosis of PTSD according to the DSM-IV-TR 
(American Psychiatric Association, 2000) and 
a summed score on the Posttraumatic Diagnostic Scale 
≥ 18. Walter et al. (2012) included patients with current 
PTSD, and Steuwe et al. (2016) included patients with 
PTSD as defined by the DSM-IV-TR. Patients with 
PTSD were allocated to an intervention by randomiza-
tion in six studies (43%). Two studies solely used trauma- 
focused self-report assessments. Fourteen studies 
reported the number of patients dropping out (100%) 
and results regarding treatment tolerability were 













Bohus et al., 2013 + + + + + + +
Harned et al., 2014 + + + + + + +
Kredlow et al., 2017 I + + + + + + +
Kredlow et al., 2017 II + + + + + + +
Feeny et al., 2002 + + + + - + -
Walter et al., 2012 - - - + - - -
Harned et al., 2012 + - + + + + +
Pabst et al., 2014 + - + + - - +
Steuwe et al., 2016 - - + + + + +
Holder et al., 2017 + + + + - + -
Meyers et al., 2017 + - Self-reports + + - -
Slotema et al., - - Self-reports + + - +
Steil et al., 2018 + - - + + + +
De Jongh et al., 2020 + - - + + - -
PTSD = posttraumatic stress disorder. 
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reported in 10 (71%). Data considering posttreatment 
and follow-up assessments were presented in nine stu-
dies (64%), with nine conducting intention-to-treat- 
analyses (64%). The four RCTs included in the meta- 
analyses fulfilled all seven quality criteria.
3.2.2. Publication bias
The results for publication bias are presented in Table 3. 
The number of studies needed to change the results (i.e. 
the fail-safe number) of the RCTs varied between 14 
and 57. For all randomized controlled, nonrandomized 
controlled and uncontrolled studies the fail-safe num-
ber varied between 52 and 3,279.
Based on the funnel plot for the meta-analysis 
regarding psychotherapy for the severity of PTSD, 
Egger’s regression intercept was 2.84 (t-value = 2.13, 
df = 12, p = 0.055), suggesting symmetry in the 
funnel plot.
Six meta-analyses could be conducted to deter-
mine the efficacy of the PTSD-focused psychothera-
pies for patients with comorbid personality disorders, 
for which purpose we evaluated the following out-
come measures: change in 1) PTSD symptom sever-
ity, 2) the severity of depressive symptoms, 3) the 
severity of anxiety, 4) the severity of borderline symp-
toms, 5) the severity of PTSD symptoms in patients 
with BPD, and 6) PTSD symptom severity at follow- 
up (at least 3 months after treatment conclusion).
The results of the meta-analyses are presented in 
Table 4 and Figures 2–8. All RCTs included patients 
with BPD and significant SDs were found for post- 
treatment PTSD symptom severity (see Figure 2) and 
at 3-month follow-up or beyond. Looking at the 
randomized -, nonrandomized controlled and uncon-
trolled studies together, significant standardized 
effect sizes were found for symptom severity of 
PTSD, depression, anxiety, borderline, PTSD in 
BPD, and PTSD 3 months (or more) post- 
treatment. The Hedges’ gs for RCTs versus all studies 
were significantly lower for reductions in the symp-
toms of PTSD and anxiety (Q = 5.08, df = 1, 
p = 0.024 and Q = 5.89, df = 1, p = 0.015, 
respectively).
3.2.3. Heterogeneity
Heterogeneity was found for effects on severity of 
PTSD (all studies), depressive symptoms (RCTs and 
all studies), borderline symptoms (all studies), 
patients with BPD (all studies) and severity of PTSD 
after at least 3 months of follow-up (all studies). Due 
to the small number of studies, it was not possible to 
conduct a meta-regression analysis including all para-
meters. As an alternative, correlations between effect 
sizes and parameters were computed per individual 
parameter. To correct for multiple testing we have 
used the Benjamini-Hochberg method. A total of 24 
tests were performed. After correction three findings 
remained significant. With all studies analysed, the 
standardized effect sizes for PTSD symptom severity 
were lower for the patients with BPD compared to 
those with several types of personality disorders 
(Q = 7.70, df = 1, p = 0.006). Studies that offered 
targeted, stand-alone psychotherapy for PTSD rather 
than as an add-on treatment reached significantly 
higher SDs for the severity of depressive symptoms 
(Q = 6.94, df = 1, p = 0.008). In addition, significant 
differences in the standardized effect sizes for out- 
compared to inpatient treatment or a combination of 
the two were found for the severity of PTSD after at 
least 3 months of follow-up (Q = 11.01, df = 2, 
p = 0.004). No specific type of setting was found to 
be superior to the others.
4. Discussion
We conducted a meta-analysis and systematic review to 
evaluate the current evidence of the effects of PTSD 
treatments for patients with personality disorders on 
the severity of PTSD and other, comorbid symptoms, 
also looking at the risks presumed to be associated with 
trauma-focused interventions and (the mean weighted) 
dropout rates. Fourteen out of 17 studies included only 
patients with BPD. All studies found eligible for review 
explored psychotherapeutic interventions, with our 
meta-analyses showing psychotherapy for PTSD to be 
superior to the control conditions in the RCTs, reaching 
Table 3. Results on the heterogeneity and publication bias for the studies included in the meta-analyses.
Q p df I2 Fail-safe number
PTSD RCTs 2.56 0.47 3 0 56
PTSD all studies 47.24 <.001 13 72.48 3,279
Depression RCTs 12.90 0.005 3 76.74 14
Depression all studies 22.34 0.004 8 64.18 436
Anxiety RCTs 0.79 0.67 2 0 0
Anxiety all studies 6.93 0.14 4 42.32 52
Borderline symptoms RCTs 4.15 0.13 2 51.82 6
Borderline symptoms all studies 15.73 0.015 6 61.86 142
PTSD patients BPD RCTs 2.56 0.47 3 0 56
PTSD patients BPD all studies 37.32 <.001 12 67.85 2,188
PTSD after 3 months RCTs 6.11 0.11 3 50.91 57
PTSD after 3 months all 20.73 0.008 8 61.40 629
BPD = borderline personality disorder, PTSD = posttraumatic stress disorder, RCTs = randomized-controlled trials. 
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a moderate posttreatment standardized effect size of 
0.54, which, at follow-up (minimum of 3 months after 
treatment completion) had increased to large (0.82). No 
significant change was observed in the severity of 
depression, anxiety, and borderline symptoms. Having 
also included the nonrandomized-controlled and 
uncontrolled studies, we found significant improve-
ment for all outcomes (i.e. severity of PTSD, depression, 
Table 4. Results of the meta-analyses of studies exploring PTSD-focused psychotherapy in patients with personality disorders.
Studies n Sample size n Hedges’ g Z p
PTSD RCTs 4 141 0.54 3.17 0.002
PTSD all studies 14 430 1.04 6.75 <.001
Depression RCTs 4 141 0.64 1.72 0.0085
Depression all studies 9 217 0.73 3.85 <.001
Anxiety RCTs 3 108 0.17 0.89 0.37
Anxiety all studies 5 130 0.48 2.48 0.013
Borderline symptoms RCTs 3 115 0.43 1.56 0.12
Borderline symptoms all studies 7 204 0.52 2.87 0.004
PTSD patients BPD RCTs 4 141 0.54 3.17 0.002
PTSD patients BPD all studies 13 295 1.04 5.94 <.001
PTSD after 3 months RCTs 4 141 0.82 3.19 0.001
PTSD after 3 months all 9 203 0.98 4.61 <.001
BPD = borderline personality disorder, PTSD = posttraumatic stress disorder, RCT = randomized-controlled trial. 
Figure 2. Meta-analysis of the four randomized-controlled trials evaluating PTSD symptom severity after trauma-focused 
psychotherapy in patients with personality disorders.
Figure 3. Meta-analysis of all studies exploring the effects of psychotherapy for posttraumatic stress disorder (PTSD) on the 
severity of PTSD in patients with personality disorders.
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anxiety, borderline symptoms, PTSD in patients with 
BPD, and PTSD symptom reductions at 3-month fol-
low-up). With 0.48 to 1.04, standardized effect sizes 
were moderate to large. Our systematic review revealed 
there was no increase in self-injurious behaviour, sui-
cide attempts, or hospitalizations during the PTSD 
interventions and the mean weighted dropout was 17%.
4.1. Moderator analyses
The results of the meta-analyses were not homoge-
neous with respect to the severity of PTSD (all stu-
dies), depressive symptoms (RCTs and all studies), 
borderline symptoms (all studies), patients with BPD 
(all studies) and severity of PTSD after at least 3 
months of follow-up (all studies). The effect sizes 
for depression were higher if the PTSD treatment 
was offered as the primary intervention and not as 
an add-on to other treatments. Although 
heterogeneity was found for the severity of PTSD at 
least 3 months of follow-up, separate analyses for in-, 
outpatient treatment and the combination of the two 
did not show one setting to be better than the others. 
Standardized effect sizes for PTSD symptom reduc-
tions were higher in the studies including patients 
with various personality disorders than they were in 
the studies treating patients with BPD only. However, 
when our group compared the effects of EMDR in 
these two populations, we did not find any differ-
ences (Slotema et al., 2019).
To our knowledge, ours is the first systematic 
review focusing on the treatment of PTSD in patients 
with personality disorders. The significant treatment 
effects we found are in line with the effect sizes 
reported in previous meta-analyses in which no dis-
tinction was made between patients with or without 
comorbid personality disorders (Bisson et al., 2007; 
Carpenter et al., 2018; Chen et al., 2014; Ehring et al., 
Figure 5. Meta-analysis of all studies exploring psychotherapy for posttraumatic stress disorder on severity of anxiety in patients 
with personality disorders.
Figure 4. Meta-analysis of all studies exploring the efficacy of psychotherapy for posttraumatic stress disorder on the severity of 
depression in patients with personality disorders.
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2014; Lewis et al., 2020). However, although in these 
studies an additional significant reduction in depres-
sion and anxiety symptoms was reported, our evalua-
tion of RCTs failed to reveal comparable effects. Also, 
risks associated with psychotherapy for PTSD were 
not discussed in these earlier meta-analyses. Our 
mean weighted dropout rate of 17% is lower to the 
rate (22%) reported by Ehring et al. (2014) in their 
systematic review of PTSD treatments for patients 
having suffered childhood abuse and the rate (29%) 
Carpenter and colleagues recorded for CBT (2018). 
Furthermore, in their meta-analysis comparing psy-
chotherapy and pharmacotherapy for PTSD, Lee et al. 
also reported an increase of the standardized effect 
size during follow-up (Lee et al., 2016).
The treatment effects we found for patients with 
personality disorders and PTSD are in line with the 
findings of studies exploring CBT, prolonged expo-
sure, EMDR, and DBT in patients with other severe 
comorbid disorders such as major depression, bipolar 
Figure 6. Meta-analysis of all studies exploring psychotherapy for posttraumatic stress disorder on severity of borderline 
symptoms in patients with personality disorders.
Figure 7. Meta-analysis of all studies exploring psychotherapy for posttraumatic stress disorder (PTSD) on severity of PTSD 
patients with borderline personality disorder.
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disorder, schizophrenia, schizoaffective disorder, sub-
stance abuse, or anxiety and eating disorders (Mueser 
et al., 2015, 2008; Sannibale et al., 2013; Steil, Dyer, 
Priebe, Kleindienst, & Bohus, 2011; Van den Berg 
et al., 2015), while the dropout rates documented 
are lower than the rate we computed in the present 
review (Mueser et al., 2015, 2008; Van den Berg et al., 
2015).
4.2. Implications for clinical practice and future 
research
Based on the studies evaluated, our review demon-
strates that psychotherapy can effectively and safely 
reduce the severity of PTSD symptoms in patients 
with personality disorders. Given that no increases 
in adverse events were reported, our findings suggest 
there is no good reason to withhold trauma-focused 
treatments from these patients.
Although moderator analyses revealed better 
results for stand-alone psychotherapy for PTSD than 
for add-on trauma-focused treatments and for EMDR 
compared to all other PTSD interventions delivered, 
the number of studies and sample sizes were too low 
to draw any firm conclusions regarding the optimal 
treatment paradigm for PTSD in this population.
More RCTs with larger patient samples are needed 
to confirm our results. As in the majority of PTSD 
studies only patients with BPD participated, it would 
be of interest to explore the efficacy of psychotherapy 
in patients with other personality disorders. Also, it 
would be worth investigating whether these patient 
groups might benefit more or more quickly from 
psychotherapy aimed at helping them manage their 
personality disorder(s) if PTSD interventions were 
offered at an early stage after their primary diagnosis 
and treatment.
4.3. Limitations
The two major limitations of this meta-analysis and 
qualitative review are the small number of RCTs and 
small patient cohorts, necessitating caution when inter-
preting the efficacy and moderator-analysis results pre-
sented. More larger-scale RCTs of PTSD treatments in 
different patient groups with well-defined PTSD and 
comorbid conditions and control samples are urgently 
needed. As in the studies we reviewed the majority of 
patients were female and diagnosed with BPD, the 
results we obtained specifically concern these popula-
tions. Also, most studies did not use structural clinical 
interviews to diagnose PTSD. Finally, various types of 
psychotherapy were used for different kinds of traumas 
with different outcome measures being employed in 
small samples, again preventing firm conclusions 
regarding the most optimal type of and setting for 
PTSD treatments and patient groups most likely to 
benefit from intervention, making more research into 
the efficacy of PTSD treatments in patients with per-
sonality disorders indispensable.
4.4. Conclusions
A broad search of the literature revealed that psy-
chotherapy was the only intervention for PTSD hav-
ing been investigated in patients with personality 
Figure 8. Meta-analysis of all studies exploring psychotherapy for posttraumatic stress disorder (PTSD) on severity of PTSD 
patients after at least three months of follow-up in patients with personality disorders.
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disorders. With significant moderate to high standar-
dized effect sizes and improvements having been 
maintained at least 3-months post-treatment, the 
meta-analyses of the four RCTs identified showed 
that patients with BPD had indeed benefitted from 
trauma-focused psychotherapy. Analyses of all stu-
dies showed similar effect sizes for reductions in 
PTSD, depression, anxiety, and borderline symptoms, 
PTSD severity in patients with BPD, with PTSD 
improvements also being maintained at follow-up 
(3 months or longer). Although further controlled 
research is warranted, based on these results, includ-
ing the findings that the risks associated with the 
PTSD interventions examined were low and the 
mean-weighted dropout rate was 17%, we suggest 
that patients with comorbid personality disorders 
also profit from and should accordingly be offered 
psychological treatment for their PTSD.
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